leisure time -WSS

leisure time

author：focus 2025-08-08 05:32:52 - browse：766

Illustration: Alex Hogan/STAT; Photo: Courtesy Perrigo

It’s not every day that a marketing team is tasked with designing the branding and packaging of the first over-the-counter birth control pill to be sold in the U.S.

This was the challenge, and the opportunity, faced by the team behind Opill, the landmark pill from drugmaker Perrigo that received approval from the Food and Drug Administration earlier this month. Their brief: Create a design that would stand out in America’s notoriously sprawling pharmacy aisles; inspire trust and confidence; be easy to remember and recognize; appeal to women — including teenagers — as well as trans men and nonbinary people; clearly communicate its purpose; be simple to carry and use; contain straightforward but accurate user information; and clear FDA requirements.

Settling on the right approach took years of research and testing, which resulted in the name Opill and packaging featuring bright teal, saturated pink, and yellow, as well as a rounded font reminiscent of millennials’ ubiquitous favorite Gotham. All of these features are intended to set the product apart from the dozens of prescription contraceptive pills available in the U.S. market and internationally.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

WSS

Intellia reports positive results for its CRISPR

Microsoft launches AI tool for clinical documentation through Epic

Change Healthcare can notify patients about the breach, HHS says

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Cord blood banking comes at a high cost to babies

focus

leisure time

hotspot

Walensky prepares to leave CDC — and Congress — behind

Ionis drug prevents swelling attacks due to hereditary angioedema

Virginia high school admissions case could be legal follow

A pediatrician calls for Congress to pass the child tax credit deal

Activists slam private health insurers over coverage restrictions

Letters to First Opinion on caregivers, digital health, and more

Walensky prepares to leave CDC — and Congress — behind

What causes osteoarthritis? Researchers study link to brain protein

Anesthesiologist group: stop taking Ozempic before surgery

With trial win, GSK could get blood cancer drug back on market

Wikipedia

Future doctors need a strong humanities education

High breast density mammograms need follow

Medicare bonuses could stop drug shortages under Senate plan

Inaction leaves children at risk from dangerous chemotherapy drug

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Dana Farber says 6 studies to be retracted and 31 corrected

focus

hotspot

explore

hotspot